PTGS2 and amyotrophic lateral sclerosis: Cyclooxygenase 2 (COX2) catalyzes the conversion of arachidonic acid to PGE2; thus, blocking COX2 specifically with celecoxib or rofecoxib may slow down the development and progression of ALS [133,134].